Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-036839
Filing Date
2025-07-31
Accepted
2025-07-31 07:25:56
Documents
93
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cbio-20250630.htm   iXBRL 10-Q 1196436
2 EX-31.1 exhibit-311.htm EX-31.1 9374
3 EX-31.2 exhibit-312.htm EX-31.2 9700
4 EX-32.1 exhibit-321.htm EX-32.1 3611
5 EX-32.2 exhibit-322.htm EX-32.2 3508
  Complete submission text file 0001628280-25-036839.txt   7157429

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cbio-20250630.xsd EX-101.SCH 61512
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cbio-20250630_cal.xml EX-101.CAL 51792
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cbio-20250630_def.xml EX-101.DEF 407028
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cbio-20250630_lab.xml EX-101.LAB 665532
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cbio-20250630_pre.xml EX-101.PRE 578185
96 EXTRACTED XBRL INSTANCE DOCUMENT cbio-20250630_htm.xml XML 655499
Mailing Address 300 FIFTH AVENUE WALTHAM MA 02451
Business Address 300 FIFTH AVENUE WALTHAM MA 02451 617-430-5595
CRESCENT BIOPHARMA, INC. (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 251169421
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)